MAPS in the Media
Weed for PTSD? Eager for Better Cannabis Science, F.D.A. Clears Study. | The New York Times
Setback Or Opportunity? FDA Rejects MDMA For PTSD | Forbes
Despite FDA setback, psychedelic pioneer Rick Doblin is unfazed about MDMA’s prospects – The Washington Post
Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy | STAT News
Opinion: FDA ruling on ecstasy for PTSD is a bad trip for suffering patients | Washington Post
Bennet, Tillis, Sinema, Paul, 15 Colleagues Call on FDA to Rely on Scientific Evidence for MDMA-Assisted Therapy to Treat Post-Traumatic Stress Disorder
Bergman Leads 60 Members in Letter to Highlight New Groundbreaking Therapy, Stop Veteran Suicide
Making Sense with Sam Harris: The Future of Psychedelic Medicine 2
The Unbelievable Claims of Psymposia about MAPS and MDMA-Assisted Therapy | Chacruna
Experts Endorse MDMA-assisted Therapy for PTSD
The State Committee of the Netherlands on MDMA: Report presentation by Wim van den Brink
View the report here.